Next, we investigated whether clinical characteristics or the major MS risk gene HLA-DRB1*15:01 and protective gene HLA-A*02:01 (34) influenced the frequency of autoantigen-specific cells (Fig. 5, A to C). Here, HLA-DRB1 is linked to myeloid sarcoma.